Embryo Invest ApS: Financial statements 2025
CVR: 42047864
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Embryo Invest ApS (CVR 42047864) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,449 and a net result of DKK 840,493 compared with DKK 8,570,903 the year before. Equity in the 2025 report amounted to DKK 12,423,903. The solvency ratio was 70.1%.
- Gross Profit
- DKK -5,449
- Profit/Loss
- DKK 840,493
- Equity
- DKK 12,423,903
- Total Assets
- DKK 17,732,204
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5K | 840K | 12.4M | 0 |
| 2024 | - | -16K | 8.6M | 11.7M | 0 |
| 2023 | - | -35K | 5M | 3.3M | 0 |
| 2022 | - | -19K | -8M | -1.7M | 0 |
| 2021 | - | -5K | 6.3M | 6.3M | 0 |
Official annual report
How creditworthy is Embryo Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Embryo Invest ApS has published its annual report for 2024. Gross profit came to DKK -16,000, and the net result was DKK 8,570,903.
About Embryo Invest ApS
Embryo Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Cathrine Olesen Emborg. The company is owned by Cathrine Olesen Emborg. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,449 and a net result of DKK 840,493 compared with DKK 8,570,903 the year before. Equity in the 2025 report amounted to DKK 12,423,903.
